BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmed KA, Berglund AE, Welsh EA, Naghavi AO, Kim Y, Yu M, Robinson TJ, Eschrich SA, Johnstone PAS, Torres-Roca JF. The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity. Neuro Oncol 2017;19:1145-6. [PMID: 28379582 DOI: 10.1093/neuonc/nox043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Peinado-Serrano J, Carnero A. Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors. Cancers (Basel) 2022;14:2202. [PMID: 35565331 DOI: 10.3390/cancers14092202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Peinado-Serrano J, Quintanal-Villalonga Á, Muñoz-Galvan S, Verdugo-Sivianes EM, Mateos JC, Ortiz-Gordillo MJ, Carnero A. A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer. Cancers (Basel) 2022;14:2054. [PMID: 35565183 DOI: 10.3390/cancers14092054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang G, Yuan Z, Ahmed K, Welsh EA, Fulp WJ, Gonzalez RJ, Mullinax JE, Letson D, Bui M, Harrison LB, Scott JG, Torres-Roca JF, Naghavi AO. Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization. Transl Oncol 2021;14:101165. [PMID: 34246048 DOI: 10.1016/j.tranon.2021.101165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Solanki AA, Venkatesulu BP, Efstathiou JA. Will the Use of Biomarkers Improve Bladder Cancer Radiotherapy Delivery? Clin Oncol (R Coll Radiol) 2021;33:e264-73. [PMID: 33867226 DOI: 10.1016/j.clon.2021.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 León-triana O, Pérez-beteta  J, Albillo D, Ortiz de Mendivil A, Pérez-romasanta L, González-del Portillo E, Llorente M, Carballo N, Arana E, Pérez-garcía VM. Brain Metastasis Response to Stereotactic Radio Surgery: A Mathematical Approach. Mathematics 2021;9:716. [DOI: 10.3390/math9070716] [Reference Citation Analysis]
6 Roth O'Brien DA, Poppas P, Kaye SM, Mahase SS, An A, Christos PJ, Liechty B, Pisapia D, Ramakrishna R, Wernicke AG, Knisely JPS, Pannullo S, Schwartz TH. Timing of Adjuvant Fractionated Stereotactic Radiosurgery Affects Local Control of Resected Brain Metastases. Pract Radiat Oncol 2021;11:e267-75. [PMID: 33578001 DOI: 10.1016/j.prro.2021.01.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Ahmed KA, Creelan BC, Peacock J, Mellon EA, Kim Y, Grass GD, Perez BA, Rosenberg SA, Dilling TJ, Eschrich SA, Chiappori AA, Torres-roca JF. A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancer.. [DOI: 10.1101/2021.01.31.21250879] [Reference Citation Analysis]
8 Guo T, Zou L, Ni J, Chu X, Zhu Z. Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy. Transl Lung Cancer Res 2020;9:2097-112. [PMID: 33209629 DOI: 10.21037/tlcr-20-511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sim AJ, Ahmed KA, Keller A, Figura NB, Oliver DE, Sarangkasiri S, Robinson TJ, Johnstone PAS, Yu HM, Naghavi AO. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases. Am J Clin Oncol 2020;43:356-61. [PMID: 32217854 DOI: 10.1097/COC.0000000000000675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Yang WC, Hsu FM, Yang PC. Precision radiotherapy for non-small cell lung cancer. J Biomed Sci 2020;27:82. [PMID: 32693792 DOI: 10.1186/s12929-020-00676-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
11 Yuan Z, Frazer M, Ahmed KA, Naqvi SMH, Schell MJ, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Torres-Roca JF, Hoffe SE, Frakes JM. Modeling precision genomic-based radiation dose response in rectal cancer. Future Oncol 2020;16:2411-20. [PMID: 32686956 DOI: 10.2217/fon-2020-0060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Aherne NJ, Dhawan A, Scott JG, Enderling H. Mathematical oncology and it's application in non melanoma skin cancer - A primer for radiation oncology professionals. Oral Oncol 2020;103:104473. [PMID: 32109841 DOI: 10.1016/j.oraloncology.2019.104473] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
13 Daniel Grass G, Alfonso JC, Welsh E, Ahmed KA, Teer JK, Harrison LB, Cleveland JL, Mulé JJ, Eschrich SA, Enderling H, Torres-roca JF. Harnessing tumor immune ecosystem dynamics to personalize radiotherapy.. [DOI: 10.1101/2020.02.11.944512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Riou O, Bourgier C, Brengues M, Bonnefoi N, Michaud HA, Castan F, Gourgou S, Draghici R, Farcy-Jacquet MP, Bons F, Fenoglietto P, Ozsahin M, Azria D. [Predictive assays for responses of tumors and normal tissues in radiation oncology]. Cancer Radiother 2019;23:666-73. [PMID: 31451357 DOI: 10.1016/j.canrad.2019.07.152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Rühle A, Andratschke N, Siva S, Guckenberger M. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? Clin Transl Radiat Oncol 2019;18:104-12. [PMID: 31341985 DOI: 10.1016/j.ctro.2019.04.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
16 Naghavi AO, Yang GQ, Latifi K, Gillies R, Mcleod H, Harrison LB. The Future of Radiation Oncology in Soft Tissue Sarcoma. Cancer Control 2018;25:107327481881550. [DOI: 10.1177/1073274818815504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Ahmed KA, Scott JG, Arrington JA, Naghavi AO, Grass GD, Perez BA, Caudell JJ, Berglund AE, Welsh EA, Eschrich SA, Dilling TJ, Torres-Roca JF. Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose. J Thorac Oncol 2018;13:1121-7. [PMID: 29733909 DOI: 10.1016/j.jtho.2018.04.027] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]